Reply to Gómez Marín

dc.creatorAna Carolina Aguiar Vasconceloscarneiro
dc.creatorAndréa Teixeira-carvalho
dc.creatorRicardo Wagner Almeida Vitor
dc.creatorOlindo Assis Martins Filho
dc.creatorAnderson da Silva Machado
dc.creatorSamantha Ribeiro Béla
dc.creatorJulia Gatti Ladeia Costa
dc.creatorGláucia Manzan Queiroz Andrade
dc.creatorDaniel Vitor Vasconcelos-santos
dc.creatorJosé Nélio Januário
dc.creatorJordana Grazziela Coelho-dos-reis
dc.creatorEloisa Amália Vieira Ferro
dc.date.accessioned2023-06-23T20:02:09Z
dc.date.accessioned2025-09-09T00:54:03Z
dc.date.available2023-06-23T20:02:09Z
dc.date.issued2016-06
dc.format.mimetypepdf
dc.identifier.doi10.1093/infdis/jiw211
dc.identifier.issn00221899
dc.identifier.urihttps://hdl.handle.net/1843/55289
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofThe Journal of Infectious Diseases
dc.rightsAcesso Aberto
dc.subjectToxoplasmose
dc.subjectCrianças
dc.subjectToxoplasma
dc.subject.otherToxoplasmosis
dc.subject.otherChildren
dc.subject.otherToxoplasma gondii
dc.titleReply to Gómez Marín
dc.typeArtigo de periódico
local.citation.epage656
local.citation.issue4
local.citation.spage656.2
local.citation.volume214
local.description.resumoTO THE EDITOR—We thank Gómez Marín for the comments. Regarding the question raised, our study was part of a population-based investigation on neonatal screening for toxoplasmosis, with a lack of prenatal treatment being the rule. Blood samples were collected when newborns were brought for confirmatory serologic testing [1] and before initiation of postnatal treatment. Our results prompted local authorities to establish a prenatalscreening program for congenital toxoplasmosis in our state, to provide prenatal treatment and possibly decrease the burden of the disease. Analysis of the immune response of these children after 1 year of postnatal treatment is nearly completed, and we are curious to know whether and how antiparasitic drugs may have affected immune responses to Toxoplasma gondii in these individuals. These results, when available, will hopefully shed further light into the immunopathogenesis and optimal immunomodulation of this infection. Notes Financial support. This work was supported by the Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), the Secretaria de Saúde de Minas Gerais, and the Núcleo de Ações e Pesquisa em Apoio Diagnóstico (NUPAD). Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted nthe ICMJE Form for Disclosure of Potential Con flicts of Interest. Conflicts that the editors consid er relevant to the content of the manuscript have been disclosed.
local.identifier.orcidhttps://orcid.org/0000-0002-0912-3782
local.publisher.countryBrasil
local.publisher.departmentICB - DEPARTAMENTO DE PARASITOLOGIA
local.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICA
local.publisher.departmentMED - DEPARTAMENTO DE OFTALMOLOGIA E OTORRINOLARINGOLOGIA
local.publisher.initialsUFMG
local.url.externahttps://academic.oup.com/jid/article/214/4/656/1751126

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
Reply to Gómez Marín pdfa.pdf
Tamanho:
85.86 KB
Formato:
Adobe Portable Document Format

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição: